AFFITOPE PD03A

PD03A · Affiris AG

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AFFITOPE PD03A, covering 2016-10-31 to 2017-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA [Phase 1]